Literature DB >> 8614941

Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats.

R N Auer1.   

Abstract

BACKGROUND AND
PURPOSE: Although N-methyl-D-aspartate (NMDA) antagonism may be a useful therapeutic approach in stroke treatment, it has been found that these pharmacological agents cause neuronal necrosis in restricted cortical regions of the rodent brain.
METHODS: To test the hypothesis that age and sex influence NMDA antagonist-induced neuronal necrosis, male and female rats were studied at 2 months (young), 12 months (middle-aged), and 24 months (old) of age. A dose of 5 mg/kg MK-801 was administered, followed by quantitation of neuronal necrosis at nine coronal levels in the cingulate and retrosplenial cortex at 1 week of survival.
RESULTS: Mortality was dependent on age but not sex and was higher in the old rats (P<.01). The number of necrotic neurons per hemisphere was greater in female than in male rats at all ages (P<.0001). Female rats also showed increasing neuronal necrosis with age (P<.05).
CONCLUSIONS: The results indicate a major sex difference in neuronal cytotoxicity caused by NMDA antagonists and a minor increase in susceptibility with increasing age in females. The findings may be relevant to development of drugs with NMDA antagonist properties for use in human stroke.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614941     DOI: 10.1161/01.str.27.4.743

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Different modes of hippocampal plasticity in response to estrogen in young and aged female rats.

Authors:  M M Adams; R A Shah; W G Janssen; J H Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

2.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

Review 3.  Glutamate-mediated excitotoxicity in schizophrenia: a review.

Authors:  Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

Review 4.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

5.  Postnatal MK-801 treatment of female rats impairs acquisition of working memory, but not reference memory in an eight-arm radial maze; no beneficial effects of enriched environment.

Authors:  Masoumeh Nozari; Farshad Alizadeh Mansouri; Mohammad Shabani; Hojat Nozari; Nafiseh Atapour
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

6.  NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity.

Authors:  Qiang Li; Suzanne Clark; Darrell V Lewis; Wilkie A Wilson
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

7.  Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Authors:  Helena M Abelaira; Thayse Rosa; Airam B de Moura; Natalia M Andrade; Nicoly S Martinello; Larissa R Maciel; Maria Eduarda M Botelho; Laura A Borba; Beatriz C Chede; Camila O Arent; Larissa Joaquim; Sandra Bonfante; Lucinéia G Danielski; Talita Tuon; Fabricia Petronilho; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

8.  Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists.

Authors:  W Zajaczkowski; M Hetman; E Nikolaev; G Quack; W Danysz; L Kaczmarek
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

9.  Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.

Authors:  Naoe Okamura; Rainer K Reinscheid; Shintaro Ohgake; Masaomi Iyo; Kenji Hashimoto
Journal:  Neuropharmacology       Date:  2009-07-02       Impact factor: 5.250

Review 10.  Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?

Authors:  Frank R Sharp; Robert L Hendren
Journal:  Epilepsy Behav       Date:  2007-04-06       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.